Statistics for Agios Pharmaceuticals (id:7735 AGIO)

Valuation metrics

Market cap

3.18B

Enterprise value

2.23B

Trailing P/E (ttm)

4.78

Forward P/E

-9.16

PEG ratio

-9.16

Price/Sales (ttm)

96.60

Price/Book (mrq)

1.95

Enterprise Value/Revenue

67.89

Enterprise Value/EBITDA

-5.56

Overview

Shares outstanding

57.03M

Float

50.51M

Shares short

4.34M

% Held by insiders

0.02%

% Held by institutions

1.07%

Average volume (10 days)

667.83K

Average volume (90 days)

Price summary

52-Week low

20.96

52-Week high

62.58

52-Week change

62.44%

Beta

0.75

50-Day moving average

47.42

200-Day moving average

40.27

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

2.05K%

Operating margin

-1,146.93%

Operational effectiveness

Return on assets

-18.18%

Return on equity

53.66%

Income statement

Revenue (ttm)

0.58

Revenue per share (ttm)

0.58

Quarterly revenue growth (yoy)

Gross profit (ttm)

23.94M

EBITDA

-401,288,000.00

Net income to common (ttm)

674.31M

Diluted EPS (ttm)

11.66

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.00B

Total cash per share (mrq)

17.62

Total debt (mrq)

60.83M

Total Debt/Equity (mrq)

3.74

Current ratio (mrq)

899.30%

Book value per share (mrq)

28.53

Cash flow

Cash flow statement

-329,161,984.00

Levered free cash flow (LFCF)

-157,062,624.00